BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17579384)

  • 1. SAR and QSAR studies on the N-terminally acylated pentapeptide agonists for GPR54.
    Tomita K; Oishi S; Cluzeau J; Ohno H; Navenot JM; Wang ZX; Peiper SC; Akamatsu M; Fujii N
    J Med Chem; 2007 Jul; 50(14):3222-8. PubMed ID: 17579384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship study on small peptidic GPR54 agonists.
    Tomita K; Niida A; Oishi S; Ohno H; Cluzeau J; Navenot JM; Wang ZX; Peiper SC; Fujii N
    Bioorg Med Chem; 2006 Nov; 14(22):7595-603. PubMed ID: 16879969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship study and NMR analysis of fluorobenzoyl pentapeptide GPR54 agonists.
    Tomita K; Oishi S; Ohno H; Fujii N
    Biopolymers; 2008; 90(4):503-11. PubMed ID: 18302161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fmoc-based solid-phase synthesis of GPR54-agonistic pentapeptide derivatives containing alkene- and fluoroalkene-dipeptide isosteres.
    Tomita K; Narumi T; Niida A; Oishi S; Ohno H; Fujii N
    Biopolymers; 2007; 88(2):272-8. PubMed ID: 17216632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of 2-acylamino-4,6-diphenylpyridine derivatives as novel antagonists of GPR54.
    Kobayashi T; Sasaki S; Tomita N; Fukui S; Kuroda N; Nakayama M; Kiba A; Takatsu Y; Ohtaki T; Itoh F; Baba A
    Bioorg Med Chem; 2010 Jun; 18(11):3841-59. PubMed ID: 20457527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase.
    Tomita K; Oishi S; Ohno H; Peiper SC; Fujii N
    J Med Chem; 2008 Dec; 51(23):7645-9. PubMed ID: 19007202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.
    Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C
    J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FMRFamide-related neuropeptides are agonists of the orphan G-protein-coupled receptor GPR54.
    Clements MK; McDonald TP; Wang R; Xie G; O'Dowd BF; George SR; Austin CP; Liu Q
    Biochem Biophys Res Commun; 2001 Jun; 284(5):1189-93. PubMed ID: 11414709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of fluorescent probes for GPR54.
    Kaneda M; Misu R; Ohno H; Hirasawa A; Ieda N; Uenoyama Y; Tsukamura H; Maeda K; Oishi S; Fujii N
    Bioorg Med Chem; 2014 Jul; 22(13):3325-30. PubMed ID: 24857775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
    Chatenet D; Dubessy C; Boularan C; Scalbert E; Pfeiffer B; Renard P; Lihrmann I; Pacaud P; Tonon MC; Vaudry H; Leprince J
    J Med Chem; 2006 Nov; 49(24):7234-8. PubMed ID: 17125276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.
    Sato H; Macchiarulo A; Thomas C; Gioiello A; Une M; Hofmann AF; Saladin R; Schoonjans K; Pellicciari R; Auwerx J
    J Med Chem; 2008 Mar; 51(6):1831-41. PubMed ID: 18307294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urotensin-II receptor ligands. From agonist to antagonist activity.
    Grieco P; Carotenuto A; Campiglia P; Marinelli L; Lama T; Patacchini R; Santicioli P; Maggi CA; Rovero P; Novellino E
    J Med Chem; 2005 Nov; 48(23):7290-7. PubMed ID: 16279788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds.
    Tamamura H; Araki T; Ueda S; Wang Z; Oishi S; Esaka A; Trent JO; Nakashima H; Yamamoto N; Peiper SC; Otaka A; Fujii N
    J Med Chem; 2005 May; 48(9):3280-9. PubMed ID: 15857134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemically and pharmacokinetically stable nonapeptide KISS1 receptor agonists with highly potent testosterone-suppressive activity.
    Asami T; Nishizawa N; Matsui H; Takatsu Y; Suzuki A; Kiba A; Terada M; Nishibori K; Nakayama M; Ban J; Matsumoto S; Tarui N; Ikeda Y; Yamaguchi M; Kusaka M; Ohtaki T; Kitada C
    J Med Chem; 2014 Jul; 57(14):6105-15. PubMed ID: 24918545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of downsized metastin (45-54) analogs with maintenance of high GPR54 agonistic activity.
    Niida A; Wang Z; Tomita K; Oishi S; Tamamura H; Otaka A; Navenot JM; Broach JR; Peiper SC; Fujii N
    Bioorg Med Chem Lett; 2006 Jan; 16(1):134-7. PubMed ID: 16242330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and activity of small molecule GPR40 agonists.
    Garrido DM; Corbett DF; Dwornik KA; Goetz AS; Littleton TR; McKeown SC; Mills WY; Smalley TL; Briscoe CP; Peat AJ
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1840-5. PubMed ID: 16439116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and QSAR of quinazoline sulfonamides as highly potent human histamine H4 receptor inverse agonists.
    Smits RA; Adami M; Istyastono EP; Zuiderveld OP; van Dam CM; de Kanter FJ; Jongejan A; Coruzzi G; Leurs R; de Esch IJ
    J Med Chem; 2010 Mar; 53(6):2390-400. PubMed ID: 20192225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening.
    Orsini MJ; Klein MA; Beavers MP; Connolly PJ; Middleton SA; Mayo KH
    J Med Chem; 2007 Feb; 50(3):462-71. PubMed ID: 17266198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.